Presentation is loading. Please wait.

Presentation is loading. Please wait.

Interstitial lung disease

Similar presentations


Presentation on theme: "Interstitial lung disease"— Presentation transcript:

1 Interstitial lung disease
Approach to ILD In collagen vascular disease Division of pulmonology Jeung Eun Park

2 Contents Definition of ILD Classification of ILD
Approach of patients with ILD ILD in collagen vascular disease

3 Interstitial lung disease (ILD)
Diffuse Interstitial Lung Disease (DILD, ILD) Diffuse Parenchymal Lung Disease (DPLD) A heterogeneous group of lung parenchymal disease by varying patterns of inflammation and fibrosis Aloveoli, alveolar epithelium, capillary endothelium The spaces between these structures Perivascular and lymphatic tissues

4 Clinical features Exertional dyspnea
CXR : Bilateral diffuse interstitial infiltrates PFT : Restrictive pattern Increased alveolar-arterial oxygen difference Absence of pulmonary infection or neoplasm Pathology : inflammation and/or fibrosis or granuloma

5 2002 ATS/ERS Classification
Interstitial lung disease ILD of known causes (drug, environ, CVD) Idiopathic Interstitial Pneumonia (IIP) Granulomatous ILD (sarcoidosis) Other forms of ILD (LAM, HX) Idiopathic Pulmonary Fibrosis (IPF) = UIP IIP other than IPF Respiratory bronchiolitis– associated interstitial lung disease Desquamative interstitial pneumonia Acute interstitial pneumonia Cryptogenic organizing pneumonia Nonspecific interstitial pneumonia Lymphocytic interstitial pneumonia 2002 ATS/ERS Classification

6 2002 ATS/ERS

7 IPF vs non-IPF Idiopathic pulmonary fibrosis (IPF) UIP
Most Common type Most Poor prognosis

8 2002 ATS/ERS

9 Radiographic features of the idiopathic interstitial pneumonias
Clinical Diagnosis Usual Radiographic Features Typical Findings on HRCT IPF Basal-predominant reticulation abnormality with volume loss Peripheral, basal, subpleural reticulation with honeycombing, traction bronchiectasis, and focal ground-glass attenuation NSIP Ground-glass and reticular opacification Peripheral, basal, subpleural, symmetrical ground-glass attenuation with irregular lines and consolidation COP Patchy bilateral consolidation Subpleural or peribronchial patchy consolidation and/or nodules AIP Diffuse ground-glass density/consolidation Diffuse consolidation and ground-glass opacification, often with lobular sparing and late traction bronchiectasis DIP Ground-glass opacity Peripheral, lower lung zone ground-glass attenuation with reticulation and/or small cysts RB-ILD Bronchial wall thickening, ground-glass opacification Diffuse bronchial wall thickening with poorly defined centrilobular nodules and patchy ground-glass opacification LIP Reticular opacities and nodules Diffuse centrilobular nodules, ground-glass attenuation, septal and bronchovascular wall thickening, and thin-walled cysts

10 UIP NSIP NSIP BOOP DAD DAD
UIP in a 63-year-old man with pSS. This image demonstrates coarse reticular opacities in both lungs with associated traction bronchiectasis and subpleural honeycombing. NSIP shows extensive ground glass abnormality, with associated reticular abnormality and traction bronchiectasis. BOOP: obtained at the level of the inferior pulmonary vein shows patchy areas of ground-glass attenuation and consolidation with a subpleural or peribronchovascular distribution in both lungs. DAD :show patchy and geographic distribution of ground-glass attenuation with consolidation bilaterally in the upper and middle lung zones DAD

11 UIP NSIP UIP: mixed pattern (정상조직과 병변 조직이 혼재) irregular interstitial fibrosis (solid arrow) with mononuclear cell infiltration and foci of fibroblastic proliferation (arrowheads). Intervening normal lung tissue is also seen (open arrows NSIP :shows uniform interstitial fibrous thickening with infiltration of a few mononuclear cells DAD shows diffuse interstitial thickening with fibroblastic proliferation and mononuclear cell infiltration. BOOP : shows intraalveolar fibroblastic plugging (arrows) in alveolar spaces and alveolar duct AIP DAD BOOP

12 Histologic Patterns of NSIP
Cellular NSIP Predominantly chronic interstitial inflammation with lymphocytes & plasma cells Fibrotic NSIP Predominantly variable extent of uniform interstitial fibrosis ± cellular component

13 Clinico–radiologic–pathologic diagnosis (CRP diagnosis)
병리학적 소견 또는 방사선학적 소견이 진단명이 아니다 !! 형태학적 소견(병리학적 소견, 방사선학적 소견)과 임상진단명을 혼돈해서는 안 된다. Clinician must R/O Connective tissue disease Drug Occupational exposure Environmental exposure Toxic fume Infection

14 Clinical Dx, if idiopathic
Histologic and clinical classification of idiotathic interstitial pneumonias Pathologic Dx Clinical Dx, if idiopathic UIP (pattern) IPF NSIP (pattern) NSIP BOOP (pattern) COP DAD (pattern) AIP LIP (pattern) LIP DIP (pattern) DIP RB-ILD (pattern) RB-ILD

15 UIP pattern IPF (idiopathic) Drugs Infections Chronic HP
Collagen vascular disease Asbestosis

16 NSIP pattern Idiopathic NSIP Collagen vascular disease HP
Drug (methotrexate, amiodarone, etc.) Infection Immunodeficiency including HIV infection

17 BOOP Pattern Idiopathic process (COP)
Organizing diffuse alveolar damage Organizing infections Organization distal to obstruction Organizing aspiration pneumonia Organizing drug reactions, fume, and toxic exposures Collagen vascular disease Extrinsic allergic alveolitis/hypersensitivity pneumonitis Eosinophilic lung disease Inflammatory bowel disease As a secondary reaction in chronic bronchiolitis As a reparative reaction around other processes (including abscesses, Wegener’s granulomatosis, neoplasms, and others)

18 Common drug-induced ILD
Antimicrobial agents Cephalosporins Isoniazid Nitrofurantoin Penicillins Sulfonamides Anti-inflammatory agents Aspirin Gold Methotrexate NSIDs Penicillamine Cardiovascular drugs Amiodarone ACEi β-Blockers Hydralazine Hydrochlorothiazide

19 Antineoplastic agents
CNS drugs Carbamazepine Chlorpromazine Imipramine Phenytoin OHA Chlorpropamide Tolazamide Tolbutamide Antineoplastic agents Bleomycin Busulfan Chlorambucil Cyclophosphamide Melphalan Mercaptopurine Mitomycin Mitomycin C Illicit drugs Cocaine Heroin Methadone Propoxyphene

20 Frequency of pulmonary involvement in various collagen vascular diseases
RadioGraphics, 2002

21 Dermatomyositis-related ILD (UIP pattern)
결체 조직 질환 (CVD)과 연관된 ILD의 예(I) : CVD-related ILD Dermatomyositis-related ILD (UIP pattern) M/41, Proximal muscle weakness Lung Bx Lung biopsy : irregular intertstitial fibrosis and mononuclear cell infiltration with subpleural predominance HRCT : Muscle Bx UIP pattern

22 Systemic Sclerosis-related ILD (NSIP)
결체 조직 질환 (CVD)과 연관된 ILD의 예(II) : CVD-related ILD Systemic Sclerosis-related ILD (NSIP) F/50, progressive dyspnea Anti-Scl-70 (+) NSIP pattern

23 Sjogren syndrome-related ILD (LIP)
결체 조직 질환 (CVD)과 연관된 ILD의 예(III) : CVD-related ILD Sjogren syndrome-related ILD (LIP) HRCT shows centrilobular nodules and branching linear structures (straight arrow) in the right lung. Many thin-walled cysts (curved arrows) were seen in both lungs. (b) Patholoty : shows diffuse lymphocyte infiltration in the peribronchovascular interstitium and surrounding alveolar septa (arrows). LIP pattern

24 Comparison of survival curves

25 Am J Respir Crit Care Med Vol, 2005

26

27 CHEST ,2006


Download ppt "Interstitial lung disease"

Similar presentations


Ads by Google